NovaBridge Biosciences
NBP
$4.26
-$0.01-0.23%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 09/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -- | 78.05% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -61.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -1.36% |
| Total Other Non-Cash Items | -- | -- | -- | -- | -80.13% |
| Change in Net Operating Assets | -- | -- | -- | -- | -91.49% |
| Cash from Operations | -- | -- | -- | -- | 73.27% |
| Capital Expenditure | -- | -- | -- | -- | 75.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 202.84% |
| Cash from Investing | -- | -- | -- | -- | 185.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -95.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 96.84% |
| Cash from Financing | -- | -- | -- | -- | -95.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 439.80% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -- | 109.75% |